Back to search

Article

LEKTI domain 6 displays anti-inflammatory action in vitro and in a murine atopic dermatitis model

2023-04-17

Abstract excerpt

Background: Lympho-epithelial Kazal-type-related inhibitor (LEKTI) is a serine protease inhibitor consisting of multiple domains. A loss of function mutation is described in Netherton patients that show severe symptoms of atopic lesions and itch. <h4>Objectives:</h4> LEKTI domain 6 (LD6) has shown strong serine protease-inhibitory action in in vitro assays and thus it was tested in vitro and in vivo for potenti...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
01ad4536-62b3-5417-accc-b49c56aeca29
DOI
10.22541/au.168170955.51009089/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
LEKTI domain 6 displays anti-inflammatory action in vitro and in a murine atopic dermatitis modelDOI 10.22541/au.168170955.51009089/v1
Select a neighboring publication to make it the new centre.